David F. Welch, Director at AntriaBio, Inc. (ANTB), bought 5,000 shares at $0.99 ($5K) on 2017-02-10, disclosed to the SEC on 2017-02-17.
Open-market purchase of $5k ANTB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| INFN | SELL | 2021-03-17 | $8.4M | — | Filing → |
| INFN | SELL | 2020-12-16 | $6.1M | — | Filing → |
| INFN | SELL | 2020-12-07 | $2.8M | — | Filing → |